****!!!!**** "Collection of a positive sample from a distance more than 2 m away from the nearest patient traffic implies the virus was in an aerosol." "A pilot SARS-CoV-2 air sampling study conducted at a clinic within a university student health care center" "Following detection of SARS-CoV-2 in air by our March 20 air-sampling study, remediation was accomplished by performing a 2-day decontamination process using a stabilized chlorine dioxide solution (VitalOxide™) delivered through a handheld electrostatic mist sprayer"

***!!!!***!!!!*** "virucidal efficacy was tested in three locations of the room after 1 hour and 2 hours of dwell time. The estimated nominal peak concentration was 15 ppmv in the room." "CD was 99.91% effective for eliminating human coronavirus OC43 in both sachet and capsule fumigant form using both ***fast and slow release mechanisms.**** Rapid fumigant application is suitable for contaminated rooms, ambulances, emergency vehicles, and many types of PPE, most particularly porous PPE materials. The gaseous state of CD allows for rapid diffusion and transfer of the virucidal stable free radical to all surfaces of PPE and indoor areas that would favor virus survival. Additionally, this work suggests CD can be effective at levels with significant margins of safety (little to no exposure and rapid degradation of residuals) providing minimal public health risks associated with the use of CD. "

2020. During the severe pandemic of coronavirus, the development and deployment of efficient disinfection technology have attracted hospitals’ attention..

****!!! (2020) ClO2 gas used to decontaminate a 4800 161m3 facility with a total ClO2 dosage of 400 ppm per hr in a single evening. "In addition, the oxidation of air pollutants such as NOx, SOx, Hg, and VOCs using ClO2 gas has been successfully demonstrated in recent research." "When ClO2 gas dissolved into aqueous solution, the reactivity of ClO2 with organic compounds is predominant to in the gas phase because of existenceof organic compounds in water generally in low concentration."

"Three gaseous decontamination technologies are examined for their suitability in reducing environmental contamination with C. difficile: gaseous hydrogen peroxide, chlorine dioxide and ozone. Air decontamination and UV-based technologies are also briefly described. We conclude that while there is a role to play for these new technologies in the decontamination of ward surfaces contaminated with C. difficile, the requirement for both a preclean before use and the limited 'in vivo' evidence means that extensive field trials are necessary to determine their cost-effectiveness in a healthcare setting."